Alnylam Days Of Inventory On Hand from 2010 to 2024

ALNY Stock  USD 244.89  1.91  0.77%   
Alnylam Pharmaceuticals Days Of Inventory On Hand yearly trend continues to be fairly stable with very little volatility. Days Of Inventory On Hand will likely drop to 99.58 in 2024. During the period from 2010 to 2024, Alnylam Pharmaceuticals Days Of Inventory On Hand regression line of annual values had r-squared of  0.02 and arithmetic mean of  462.01. View All Fundamentals
 
Days Of Inventory On Hand  
First Reported
2010-12-31
Previous Quarter
104.82493895
Current Value
99.58
Quarterly Volatility
1.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Alnylam Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alnylam Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 56.8 M, Interest Expense of 127.3 M or Other Operating Expenses of 2.2 B, as well as many indicators such as Price To Sales Ratio of 12.42, Dividend Yield of 0.0 or Days Sales Outstanding of 63.31. Alnylam financial statements analysis is a perfect complement when working with Alnylam Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Alnylam Pharmaceuticals Correlation against competitors.
For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.

Latest Alnylam Pharmaceuticals' Days Of Inventory On Hand Growth Pattern

Below is the plot of the Days Of Inventory On Hand of Alnylam Pharmaceuticals over the last few years. It is Alnylam Pharmaceuticals' Days Of Inventory On Hand historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alnylam Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Days Of Inventory On Hand10 Years Trend
Pretty Stable
   Days Of Inventory On Hand   
       Timeline  

Alnylam Days Of Inventory On Hand Regression Statistics

Arithmetic Mean462.01
Geometric Mean0.06
Coefficient Of Variation269.01
Mean Deviation636.22
Median0.000027
Standard Deviation1,243
Sample Variance1.5M
Range4.9K
R-Value0.15
Mean Square Error1.6M
R-Squared0.02
Significance0.59
Slope42.18
Total Sum of Squares21.6M

Alnylam Days Of Inventory On Hand History

2024 99.58
2023 104.82
2022 278.83
2021 319.57
2020 431.64
2019 820.65
2018 4875.04

About Alnylam Pharmaceuticals Financial Statements

Alnylam Pharmaceuticals investors use historical fundamental indicators, such as Alnylam Pharmaceuticals' Days Of Inventory On Hand, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Alnylam Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 104.82  99.58 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Alnylam Stock Analysis

When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.